Search

Your search keyword '"Rohde, Marius"' showing total 114 results

Search Constraints

Start Over You searched for: Author "Rohde, Marius" Remove constraint Author: "Rohde, Marius"
114 results on '"Rohde, Marius"'

Search Results

1. Irinotecan and temozolomide in combination with dasatinib and rapamycin versus irinotecan and temozolomide for patients with relapsed or refractory neuroblastoma (RIST-rNB-2011): a multicentre, open-label, randomised, controlled, phase 2 trial

2. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

3. Pneumocystis jirovecii pneumonia in paediatric acute lymphoblastic leukaemia: A report from the multi‐international clinical trial AIEOP‐BFM ALL 2009

4. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1β release by mononuclear phagocytes

6. Determinants of patient and physician global assessments of disease activity in anti-neutrophil cytoplasmic antibody-associated vasculitis

7. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

9. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

10. Prehospital emergency medicine for children receiving palliative home care in Germany—a cross-sectional, exploratory study of EMS providers

11. Combined burden and functional impact tests for cancer driver discovery using DriverPower

12. Integrative pathway enrichment analysis of multivariate omics data

13. Pathway and network analysis of more than 2500 whole cancer genomes

14. Activation of endothelial NO synthase and P2X7 receptor modification mediates the cholinergic control of ATP-induced interleukin-1ß release by mononuclear phagocytes

15. Divergent mutational processes distinguish hypoxic and normoxic tumours

16. Genomic footprints of activated telomere maintenance mechanisms in cancer

17. Cardiopulmonary resuscitation in pediatric patients under palliative home care – A multicenter retrospective study

18. MINCR is a MYC-induced lncRNA able to modulate MYC’s transcriptional network in Burkitt lymphoma cells

19. The genomic and transcriptional landscape of primary central nervous system lymphoma

21. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and pCF3-diEPP

22. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and pCF3-diEPP

23. Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age

25. The landscape of genomic alterations across childhood cancers

26. Sequential karyotyping in Burkitt lymphoma reveals a linear clonal evolution with increase in karyotype complexity and a high frequency of recurrent secondary aberrations

28. The landscape of genomic alterations across childhood cancers

29. Pan-cancer analysis of whole genomes

30. Comparison of the Anti-inflammatory Properties of Two Nicotinic Acetylcholine Receptor Ligands, Phosphocholine and p CF3-diEPP.

31. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

32. Genomic and transcriptomic changes complement each other in the pathogenesis of sporadic Burkitt lymphoma

33. The landscape of genomic alterations across childhood cancers

34. Lebensbedrohliches Hautemphysem nach banalem Stoß gegen den Hals

36. Alterations of miRNAs and miRNA-regulated mRNA expression in GC B cell lymphomas determined by integrative sequencing analysis

38. MINCR is a MYC-induced lncRNA able to modulate MYC's transcriptional network in Burkitt lymphoma cells

39. The PCBP1 gene encoding poly(rc) binding protein i is recurrently mutated in Burkitt lymphoma

41. Alterations of microRNA and microRNA-regulated messenger RNA expression in germinal center B-cell lymphomas determined by integrative sequencing analysis

42. Frequency and relevance of genetic alterations of the ID3-TCF3-CCND3 pathway in pediatric mature B-cell Non-Hodgkin lymphoma

43. Incidence and prognostic relevance of genetic variations in T-cell lymphoblastic lymphoma in childhood and adolescence

44. Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial.

45. Einsatz von studentischen Prüfern in komplexeren OSCE-Prüfungen

46. New Insights into Potential Driver Mutations in Pediatric Burkitt Lymphoma

49. Abstract 3092: PTEN mutations correlate with relapse risk in pediatric T-cell lymphoblastic lymphoma patients: Validation of whole exome sequencing results

Catalog

Books, media, physical & digital resources